UNSPSC 85813131: Introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0J728

UNSPSC 85813131 Introduction of oxazolidinones into biliary and pancreatic tract via natural or artificial opening is a Commodity code that shows minimal alignment between its nominal medical procedure scope and recent state and local procurement activity. State and local governments do not appear to be soliciting this specific pharmaceutical administration service through formal competitive procurement.

The available recent opportunities tagged under this code—including virtual urgent care services (Inland Empire Health Plan, RFI), general medical services (DeKalb County, RFP), and comprehensive behavioral health and specialty services across multiple issuing bodies—represent healthcare service procurement broadly rather than the targeted procedural intervention the code describes. No issuing body has posted a solicitation specifically for oxazolidinone administration into biliary or pancreatic tracts. The mismatch suggests either miscoding of opportunities or that this particular Commodity sits outside typical state and local procurement workflows. Geographic activity spans California, Georgia, Nevada, and scattered other states, but the opportunities do not reflect demand for the procedure named in the code.